Interview: AbiVax Equipped To Enter Anti-Inflammatory Market

 
• By Kevin Grogan

The French biotech's CEO tells Scrip the firm now has the time and resources to sign up a big pharma partner for its ulcerative colitis, RA and Crohn’s candidate.

Eiffel tower
Paris-based Abivax maps out its future • Source: Shutterstock

More from Financing

More from Business